Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
FDA Approval Summary: Sotorasib for KRAS G12C-Mutated Metastatic NSCLC
Erica C. Nakajima et al.
CLINICAL CANCER RESEARCH (2022)
Current Advances in RNA Therapeutics for Human Diseases
Hannah Zogg et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
NF-κB: A Double-Edged Sword Controlling Inflammation
Danhui Liu et al.
BIOMEDICINES (2022)
Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Development of 5-FU-modified tumor suppressor microRNAs as a platform for novel microRNA-based cancer therapeutics
John G. Yuen et al.
MOLECULAR THERAPY (2022)
Current treatments for non-small cell lung cancer
Qianqian Guo et al.
FRONTIERS IN ONCOLOGY (2022)
Roles of microRNAs in Gastrointestinal Cancer Stem Cell Resistance and Therapeutic Development
Ga-Ram Hwang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
Suzan M. Hammond et al.
EMBO MOLECULAR MEDICINE (2021)
Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines
Rodolfo L. Chavez-Dominguez et al.
FRONTIERS IN ONCOLOGY (2021)
Clinical Acquired Resistance to KRASG12C Inhibition through a novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS-MAPK Reactivation
Noritaka Tanaka et al.
CANCER DISCOVERY (2021)
Vertical Pathway Inhibition Overcomes Adaptive Feedback Resistance to KRASG12C Inhibition
Meagan B. Ryan et al.
CLINICAL CANCER RESEARCH (2020)
Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility
Mihnea Paul Dragomir et al.
GUT (2020)
Functional Significance and Therapeutic Potential of miR-15a Mimic in Pancreatic Ductal Adenocarcinoma
Shixiang Guo et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers
Young Hwa Soung et al.
CANCERS (2020)
Development of syngeneic murine cell lines for use in immunocompetent orthotopic lung cancer models
Kyle Nolan et al.
CANCER CELL INTERNATIONAL (2020)
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors
David S. Hong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
In silico analysis of the prognostic value of FAS mRNA in malignancies
Zhigang Chen et al.
JOURNAL OF CANCER (2020)
High Mobility Group Box-1 (HMGB1): A Potential Target in Therapeutics
Eyaldeva C. Vijayakumar et al.
CURRENT DRUG TARGETS (2019)
Targeting ZEB2 By microRNA-129 InNon-Small Cell Lung Cancer Suppresses Cell Proliferation, Invasion And Migration Via RegulatingWnt/beta-Catenin Signaling Pathway And Epithelial-Mesenchymal Transition
Xingtao Li et al.
ONCOTARGETS AND THERAPY (2019)
Chemotherapy for Lung Cancer in the Era of Personalized Medicine
Seung Hyeun Lee
TUBERCULOSIS AND RESPIRATORY DISEASES (2019)
Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1
Andrew Fesler et al.
ONCOTARGET (2018)
p53-inducible DPYSL4 associates with mitochondrial supercomplexes and regulates energy metabolism in adipocytes and cancer cells
Hidekazu Nagano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Systematic Screening of Commonly Used Commercial Transfection Reagents towards Efficient Transfection of Single-Stranded Oligonucleotides
Tao Wang et al.
MOLECULES (2018)
p53-Mediated Molecular Control of Autophagy in Tumor Cells
Maria Mrakovcic et al.
BIOMOLECULES (2018)
Cellular uptake and trafficking of antisense oligonucleotides
Stanley T. Crooke et al.
NATURE BIOTECHNOLOGY (2017)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Development of novel miR-129 mimics with enhanced efficacy to eliminate chemoresistant colon cancer stem cells
Ning Wu et al.
Oncotarget (2017)
Understanding and targeting resistance mechanisms in NSCLC
Julia Rotow et al.
NATURE REVIEWS CANCER (2017)
MiR-129-5p inhibits non-small cell lung cancer cell sternness and chemoresistance through targeting DLK1
Zheng Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Predictors of chemotherapy efficacy in non-small-cell lung cancer: a challenging landscape
K. A. Olaussen et al.
ANNALS OF ONCOLOGY (2016)
MicroRNA-129 in Human Cancers: from Tumorigenesis to Clinical Treatment
Yanping Gao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
Maxim V. Kuleshov et al.
NUCLEIC ACIDS RESEARCH (2016)
Targeted Therapy and Immunotherapy for Lung Cancer
Evan C. Naylor et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2016)
The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinoma
Anna Biernacka et al.
CANCER GENETICS (2016)
MiRNA-Target Interaction Reveals Cell-Specific Post-Transcriptional Regulation in Mammalian Cell Lines
Varun Kulkarni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
MicroRNA Therapeutics: the Next Magic Bullet?
Bridget Simonson et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2015)
MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer
Jun Li et al.
TUMOR BIOLOGY (2015)
Predicting effective microRNA target sites in mammalian mRNAs
Vikram Agarwal et al.
ELIFE (2015)
Collateral Chemoresistance to Anti-Microtubule Agents in a Lung Cancer Cell Line with Acquired Resistance to Erlotinib
Hiroshi Mizuuchi et al.
PLOS ONE (2015)
Poor response to erlotinib in patients with tumors containing baseline EGFR T790M mutations found by routine clinical molecular testing
H. A. Yu et al.
ANNALS OF ONCOLOGY (2014)
HMGB1-dependent and -independent autophagy
Xiaofang Sun et al.
AUTOPHAGY (2014)
MicroRNAs: a new key in lung cancer
Yunlong Zhang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma
Banzhou Pan et al.
MOLECULAR CANCER (2014)
In-Depth Analysis Shows Synergy between Erlotinib and miR-34a
Jane Zhao et al.
PLOS ONE (2014)
Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool
Edward Y. Chen et al.
BMC BIOINFORMATICS (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
miR-129 promotes apoptosis and enhances chemosensitivity to 5-fluorouracil in colorectal cancer
M. Karaayvaz et al.
CELL DEATH & DISEASE (2013)
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Alex Chang
LUNG CANCER (2011)
Inflammation meets cancer, with NF-κB as the matchmaker
Yinon Ben-Neriah et al.
NATURE IMMUNOLOGY (2011)
Treatment of Non-Small-Cell Lung Cancer with Erlotinib or Gefitinib
Vince D. Cataldo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
Ranit Kedmi et al.
BIOMATERIALS (2010)
miR-129 regulates cell proliferation by downregulating Cdk6 expression
Junjie Wu et al.
CELL CYCLE (2010)
Endogenous HMGB1 regulates autophagy
Daolin Tang et al.
JOURNAL OF CELL BIOLOGY (2010)
Identification of a Molecular Signaling Network that Regulates a Cellular Necrotic Cell Death Pathway
Junichi Hitomi et al.
CELL (2008)
Fluorine in medicinal chemistry
Sophie Purser et al.
CHEMICAL SOCIETY REVIEWS (2008)
MicroRNAs modulate the chemosensitivity of tumor cells
Paul E. Blower et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Regulation of autophagy by cytoplasmic p53
Ezgi Tasdemir et al.
NATURE CELL BIOLOGY (2008)
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Cai-Hong Yun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Pivotal role of the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy
Keishi Fujiwara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Self-eating and self-killing: crosstalk between autophagy and apoptosis
M. Chiara Maiuri et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Prevalence of in vitro extreme chemotherapy resistance in resected nonsmall-cell lung cancer
TA d'Amato et al.
ANNALS OF THORACIC SURGERY (2006)
Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition
S Thomson et al.
CANCER RESEARCH (2005)
Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy
S Pattingre et al.
CELL (2005)
Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells
A Thelemann et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile
E Giovannetti et al.
BRITISH JOURNAL OF CANCER (2005)
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets
BP Lewis et al.
CELL (2005)
Real-time expression profiling of microRNA precursors in human cancer cell lines
JM Jiang et al.
NUCLEIC ACIDS RESEARCH (2005)
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
